Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer

Stockholders to also receive two contingent value rights valued at $1 per share, each entitled to be received upon the achievement of certain milestones Offer represents an approximate 85% premium ...
agr.wa.gov

Air quality recommendation for sulfur dioxide designation

We are recommending to EPA to designate all areas in Washington as "attainment/unclassifiable" for the 2024 national ambient air quality standard for sulfur dioxide ...
The Pharma Letter

FDA grants Axsome’s AXS-05 sNDA priority review designation

The US Food and Drug Administration (FDA) has accepted for filing Axsome Therapeutics’ (Nasdaq: AXSM) supplemental New Drug Application (NDA) for AXS-05 (dextromethorphan HBr and bupropion HCl) for ...